Xcout IntelSign inSubscribe

Prince Biotech, Inc.

BiotechnologyMason, OH, United States

Prince Biotech, Inc. is a biotechnology company that researches and develops immunotherapy and regenerative medicine treatments based on Preimplantation Factor (PIF) and its synthetic analog, sPIF. The company focuses on addressing unmet medical needs in areas such as autoimmune diseases, traumatic brain injury, acute radiation syndrome, stroke, and reproductive medicine through diagnostic tests designed to improve IVF success rates.

Subscribe to see Prince Biotech, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

Prince Biotech, Inc. at a glance

Prince Biotech, Inc. is a biotechnology company headquartered in Mason, United States. Its most recent funding round raised $10M in October 2025. Xcout tracks 12 named people at Prince Biotech, Inc., including Douglas C. Prince, M.D. (Chief Executive Officer, board chair).

As of 16 November 2026. Source: Xcout Intel.

Industry
Biotechnology
Headquarters
Mason, OH, United States

Prince Biotech, Inc. leadership

  • Douglas C. Prince, M.D.Chief Executive Officer, board chair
  • Douglas PrincePresident
  • Brian Huber, Ph.D.Chief Operating Officer
  • Jay S. LevyChief Financial Officer, board Member
  • Aaron N. PrinceChief Administrative Officer
  • Dr. Eytan BarneaChief Science Officer

6 more named people on record for Prince Biotech, Inc., with roles, board committees and tenure — see the full roster →

Prince Biotech, Inc. funding rounds

Every round on record:

DateRoundAmountInvestors
SEC Form D filing$10M—

Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →

Prince Biotech, Inc. competitors

A few of Prince Biotech, Inc.'s closest competitors — see the full list of competitors and alternatives →

Precigen, Inc.PGEN · BiotechGermantown, MD, United States
63% matchPublic

Precigen, Inc. is an American company dedicated to the discovery and development of cutting-edge gene and cellular therapies. The company also offers disease-modifying treatments, genetically engineered swine for regenerative medicine, and advanced reproductive and embryo transfer technologies. Its extensive portfolio of proprietary platforms includes UltraVector, which leverages advanced DNA construction and computational modeling to engineer complex gene expression programs; mbIL15, a gene designed to enhance immune cell function; the non-viral Sleeping Beauty transposon/transposase system for genetic modification; and AttSite recombinases, tools for precise DNA recombination. Furthermore, Precigen utilizes its AdenoVerse platform, a library of engineered adenovectors for gene delivery and immunotherapy applications, alongside L. lactis, a food-grade bacterium. The company also provides RheoSwitch, an inducible gene switch system offering quantitative, dose-proportionate control over target protein expression's timing and amount; kill switches, designed to selectively eliminate cell therapies within the body; tissue-specific promoters for targeted gene expression; the UltraCAR-T platform for cancer treatment; and the ActoBiotics platform, which employs genetically modified bacteria to deliver proteins and peptides directly to mucosal sites. Precigen maintains strategic collaboration and license agreements with Alaunos Therapeutics, Inc., Ares Trading S.A., Oragenics, Inc., Castle Creek Biosciences, Inc., and Intrexon Energy Partners I and II, LLC. Established in 1998, Precigen, Inc., previously known as Intrexon Corporation, adopted its current name in January 2020 and is headquartered in Germantown, Maryland.

Market cap$1.6B
Employees143
Precigen, Inc. competitors & alternatives →

Get Prince Biotech, Inc.'s news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Something wrong or missing about Prince Biotech, Inc.? Suggest a correction · Work at Prince Biotech, Inc.? Claim this profile

Is this your company? Add the Xcout Intel badge to your website

Free, for any company on Xcout Intel. It links visitors to this profile.

Prince Biotech, Inc. on Xcout Intel

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

Prince Biotech, Inc. — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on Prince Biotech, Inc. in Xcout Intel

  • 12 named people with titles, LinkedIn and board committees
  • 1 funding round with the investors in each, and who they co-invest with
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →